Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Anat Ilivitzki"'
Autor:
Karin Yaacoby-Bianu, Zeev Schnapp, Ilana Koren, Anat Ilivitzki, Mohamed Khatib, Nadeem Shorbaji, Michal Shteinberg, Galit Livnat
Publikováno v:
BMC Pharmacology and Toxicology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Lumacaftor/Ivacaftor (LUM-IVA), a cystic fibrosis transmembrane conductance regulator (CFTR) protein corrector-potentiator combination, improves lung function and reduces pulmonary exacerbations (PEx) in F508del homozygous CF pati
Externí odkaz:
https://doaj.org/article/9a7b4f48f9e34e78b521273bb0ab64c2
Publikováno v:
Rambam Maimonides Medical Journal, Vol 11, Iss 3, p e0024 (2020)
Coronavirus disease-19 (COVID-19) is a pandemic infectious disease caused by a novel coronavirus. Infection can result in a wide range of clinical outcomes, from an asymptomatic condition to severe bilateral pneumonia and life-threatening conditions.
Externí odkaz:
https://doaj.org/article/1fa2b3fbd3a84c2fbac96930fc736257
Autor:
Ronen Bar-Yoseph, Anat Ilivitzki, Dan M Cooper, Michal Gur, Gur Mainzer, Fahed Hakim, Galit Livnat, Zeev Schnapp, George Shalloufeh, Merav Zucker-Toledano, Yael Subar, Lea Bentur
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217491 (2019)
BackgroundBronchiectasis is associated with morbidity, low exercise capacity and poor quality of life. There is a paucity of data on exercise capacity using cardiopulmonary exercise test (CPET) in non-cystic fibrosis (CF) bronchiectasis. Our aim was
Externí odkaz:
https://doaj.org/article/179047befec04c158426af709188dec5
Autor:
Ahmad Assalia, Anat Ilivitzki
Publikováno v:
Notfallchirurgie des Abdomens ISBN: 9783662664087
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae91e27f37b6b9f05eb6e56fc2a93da2
https://doi.org/10.1007/978-3-662-66409-4_29
https://doi.org/10.1007/978-3-662-66409-4_29
Autor:
Naim Shehadeh, Mogher Khamaisi, Smadar Shilo, Michal Cohen, Anat Ilivitzki, Raya Gendelman, Hiba Yaseen, Ram Weiss, Nehama Zuckerman-Levin
Publikováno v:
Pediatric Diabetes. 22:916-923
AIMS Better understanding of the timeline and risk factors for the appearance of complications in pediatric Type-1-diabetes is key for developing prevention strategies. We studied endothelial markers and their determinants in adolescents with Type-1-
Autor:
Yazeed Toukan, Anat Ilivitzki, Michal Gur, Michal Scolnik, Lea Bentur, Ronen Bar-Yoseph, Luda Glozman
Publikováno v:
Pediatric Radiology. 51:1907-1916
Pulmonary nodules present a diagnostic challenge when they appear as atypical metastases in pediatric oncology patients. Chest computed tomography (CT) is the primary imaging modality for assessing lung nodules. In pediatric populations, Wilms tumor
Autor:
Boris Sokolovski, Michal Scolnik, Anat Ilivitzki, Leonid Malkin, Sergey Postovsky, Myriam Weyl Ben-Arush
Publikováno v:
Diagnostic Cytopathology. 49:817-821
BACKGROUND Accurate and swift tissue diagnosis is extremely important for the timely initiation of treatment in pediatric oncology. In our department, ultrasound-guided core needle biopsy (US-guided CNB) is used for tissue diagnosis. In 2016, we adde
Autor:
Anat Ilivitzki, Boris Sokolovski, Sergey Postovsky, Ahmad Assalia, Myriam Weyl Ben-Arush, Ayelet Ben-Barak, Luda Glozman
Publikováno v:
American Journal of Roentgenology. 216:1066-1073
OBJECTIVE. Percutaneous imaging-guided core needle biopsies (CNBs) for cancer diagnosis in pediatric patients are gaining interest because of their availability, lower rate of complications, and high diagnostic power compared with traditional surgica
Publikováno v:
Journal of Clinical Medicine. 12:1918
Pleuropulmonary blastoma (PPB) is a tumor occurring almost exclusively in infants and young children. This is the most common primary-lung malignancy in childhood. There is age-associated progression through a distinctive sequence of pathologic chang
Autor:
L. Bentur, Moneera Hanna, Kamal Masarweh, Michal Gur, Adi Weichhendler, Ronen Bar-Yoseph, Yazeed Toukan, Anat Ilivitzki, Yael Ben-David
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 15
Journal of Clinical Medicine, Vol 10, Iss 3316, p 3316 (2021)
Volume 10
Issue 15
Journal of Clinical Medicine, Vol 10, Iss 3316, p 3316 (2021)
Assessing disease severity in patients with cystic fibrosis (CF) is essential when directing therapies. Serum immunoglobulin G (IgG) levels increase with disease severity. Lung clearance index (LCI) is recognized as an outcome measure for CF clinical